Resectable Mucosal Melanoma Clinical Trials in Guangzhou, Guangdong

Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma